Cadaveric small bowel and small bowel-liver transplantation in humans.

PubWeight™: 2.75‹?› | Rank: Top 1%

🔗 View Article (PMC 2962580)

Published in Transplantation on February 01, 1992

Authors

S Todo1, A G Tzakis, K Abu-Elmagd, J Reyes, J J Fung, A Casavilla, K Nakamura, A Yagihashi, A Jain, N Murase

Author Affiliations

1: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.

Articles citing this

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42

Abdominal multivisceral transplantation. Transplantation (1995) 1.37

Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28

Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg (1993) 1.02

Themes of liver transplantation. Hepatology (2010) 0.98

History of clinical transplantation. World J Surg (2000) 0.91

The effect of small bowel transplantation on the morphology and physiology of intestinal muscle: a comparison of autografts versus allografts in dogs. Transplantation (1997) 0.90

Intestinal transplantation in humans under FK 506. Transplant Proc (1993) 0.90

The spectrum of action of new immunosuppressive drugs. Clin Exp Immunol (1992) 0.87

FK506 in solid organ transplantation. Ther Drug Monit (1995) 0.85

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev (1993) 0.84

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. J Invest Surg (1996) 0.79

Current status of intestinal transplantation. Adv Surg (1994) 0.78

Modified technique for combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.77

The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76

Modifications in combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.75

In situ proliferating status of mononuclear cells in rat small bowel grafts. Int J Exp Pathol (1995) 0.75

Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc (1992) 0.75

Is rejection a diffuse or localized process in small-bowel transplantation? Surg Endosc (1994) 0.75

Auxiliary en-bloc liver-small bowel transplantation with partial pancreas preservation in pigs. World J Gastroenterol (2004) 0.75

Articles cited by this

Evolution of liver transplantation. Hepatology (1982) 19.54

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

The physiological response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Ann Surg (1959) 3.10

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Transplantation of stomach, intestine, and pancreas: experimental and clinical observations. Surgery (1967) 2.49

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15

Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71

Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65

Small bowel transplantation. Transplantation (1984) 1.59

Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45

Lymphocyte infiltration patterns in rat small-bowel transplants. Transplant Proc (1990) 1.34

Small-bowel transplantation: European experience. Lancet (1990) 1.25

Small-bowel transplantation in children. Transplant Proc (1990) 1.10

Use of kinetic methods to evaluate D-xylose malabsorption in patients. J Lab Clin Med (1988) 1.04

What role for passenger leucocytes in small-bowel allografts? Transplant Proc (1990) 0.84

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52

The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions. Annu Rev Biochem (1978) 7.96

Urban residential environments and senior citizens' longevity in megacity areas: the importance of walkable green spaces. J Epidemiol Community Health (2002) 7.79

Kidney transplantation under FK 506. JAMA (1990) 7.45

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature (2000) 6.49

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Effects of heating in dodecyl sulfate solution on the conformation and electrophoretic mobility of isolated major outer membrane proteins from Escherichia coli K-12. J Biochem (1976) 5.52

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

DNA sequence of the gene for the outer membrane lipoprotein of E. coli: an extremely AT-rich promoter. Cell (1979) 4.31

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli. J Bacteriol (1990) 3.78

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem (1994) 3.75

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69

Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc Natl Acad Sci U S A (1982) 3.44

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Parallel neural networks for learning sequential procedures. Trends Neurosci (1999) 3.35

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Redox regulation of cellular activation. Annu Rev Immunol (1997) 3.17

Calreticulin: one protein, one gene, many functions. Biochem J (1999) 3.16

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11

Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut (2007) 3.11

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol (1994) 3.05

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Different sensitivity to wortmannin of two vacuolar sorting signals indicates the presence of distinct sorting machineries in tobacco cells. J Cell Biol (1995) 2.93

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Calreticulin is essential for cardiac development. J Cell Biol (1999) 2.88

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Synergistic release of Ca2+ from IP3-sensitive stores evoked by synaptic activation of mGluRs paired with backpropagating action potentials. Neuron (1999) 2.79

Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer (1984) 2.78

Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75

THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75

Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2.72

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther (1985) 2.69

Construction of versatile expression cloning vehicles using the lipoprotein gene of Escherichia coli. EMBO J (1982) 2.68

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Distribution of the insertion sequence IS1 in gram-negative bacteria. Nature (1981) 2.63

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res (2001) 2.62

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61

Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A (2000) 2.58

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

K-ras is essential for the development of the mouse embryo. Oncogene (1997) 2.57

Messenger ribonucleic acid of the lipoprotein of the Escherichia coli outer membrane. II. The complete nucleotide sequence. J Biol Chem (1980) 2.57